that China is considering easing rules that cap foreign investment in domestic publicly traded companies.
— Shares of the biotech firm rose nearly 4% in premarket trading after the company reported positive topline results from a clinical trial of treatment for patients with previously untreated bladder cancer. The results showed the treatment improved both overall survival and progression-free survival, compared with chemotherapy.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Canada Latest News, Canada Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
These Stocks Are Moving the Most Today: Ford, Activision, Alibaba, U.S. Steel, Scholastic, and MoreThe United Auto Workers union has threatened to expand its strike against the Big Three automakers on Friday, Microsoft’s acquisition of Activision...
Source: MarketWatch - 🏆 3. / 97 Read more »
Alibaba, JD.com Stocks Rise on Report of China Easing Ownership LimitsAuthorities are trying to nurture a recovery that has stumbled this year after pandemic lockdowns were lifted at the end of 2022.
Source: MarketWatch - 🏆 3. / 97 Read more »
Japanese stocks fall for third day as Hong Kong stocks dropStocks in the Asia-Pacific region mostly tumbled Thursday, Sept. 21, with shares in Hong Kong declining for the second day and the Japanese market showing a...
Source: MarketWatch - 🏆 3. / 97 Read more »
Japanese stocks fall for fourth session as Hong Kong stocks gainAsia-Pacific stocks mostly increased Friday, Sept. 22, the Japanese market showing a fourth day of decreases. Hong Kong's Hang Seng Index gained 2.3% to...
Source: MarketWatch - 🏆 3. / 97 Read more »
Scholastic stock tumbles on loss, Activision share rises on Microsoft deal news and more moving stocksActivision Blizzard, AstraZeneca, Scholastic, Faraday Futures, Alibaba and NIO were the most active stocks ahead of Friday's market open.
Source: MarketWatch - 🏆 3. / 97 Read more »